AUM $1.7MER 0.49%NAV $28.59Holdings 52Inception Jan 2026
Price Chart
Key Statistics
Previous Close
$28.15Day Range
$27.50$27.98
52-Week Range
$22.40$31.67
Avg Volume
432Dividend Yield
0.03%Expense Ratio
0.49%AUM
$1.7MShares Outstanding
39.7KETF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Technology | 56.26% |
| Healthcare | 36.48% |
| Communication Services | 3.65% |
| Consumer Cyclical | 3.61% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 98.37% |
| Switzerland | 1.63% |
Fund Information
- Issuer
- Pacer
- Category
- Technology
- Types
- S&P 500
- Inception Date
- Jan 12, 2026
- Exchange
- BATS
- Description
- A strategy driven exchange traded fund that aims to provide capital appreciation by selecting 50 S&P 500 companies with the highest Research & Development (R&D)expenditures, screened for free cash flow (FCF) quality.
Similar ETFs
The Pacer S&P 500 Quality FCF R&D Leaders ETF (QFRD) is an exchange-traded fund issued by Pacer that launched on Jan 12, 2026. It currently manages $1.7M in assets under management. The fund charges an expense ratio of 0.49%. The fund holds 52 securities in its portfolio. It falls under the Technology category.
Top 10 holdings represent 32.2% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | REGN | Regeneron Pharmaceuticals Inc | 4.21% | 77 | $71K |
| 2 | INCY | Incyte Corp | 3.81% | 555 | $64K |
| 3 | VRTX | Vertex Pharmaceuticals Inc | 3.58% | 116 | $60K |
| 4 | WDAY | Workday Inc | 3.40% | 331 | $57K |
| 5 | CDNS | Cadence Design Systems Inc | 3.20% | 177 | $54K |
| 6 | SNPS | Synopsys Inc | 3.19% | 125 | $54K |
| 7 | LLY | Eli Lilly & Co | 2.88% | 36 | $49K |
| 8 | CRWD | Crowdstrike Holdings Inc | 2.73% | 189 | $46K |
| 9 | ADSK | Autodesk Inc | 2.64% | 183 | $45K |
| 10 | META | Meta Platforms Inc | 2.55% | 72 | $43K |
| 11 | BIIB | Biogen Inc | 2.52% | 172 | $43K |
| 12 | VEEV | Veeva Systems Inc | 2.48% | 159 | $42K |
| 13 | MRK | Merck & Co Inc | 2.43% | 308 | $41K |
| 14 | GILD | Gilead Sciences Inc | 2.34% | 237 | $39K |
| 15 | EW | Edwards Lifesciences Corp | 2.30% | 374 | $39K |
Page 1 of 2
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | -2.30% | |
| 1W | -7.53% | |
| 1M | -12.15% | |
| 3M | -7.96% | |
| 6M | -3.23% | |
| YTD | +8.99% | |
| 1Y | +8.99% | |
| 3Y | +8.99% | |
| 5Y | +8.99% |
Moving Averages
20-Day MA
$29.69
Below 20-Day MA50-Day MA
$30.31
Below 50-Day MA200-Day MA
$27.42
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$31.67
Current Price
$27.50
52-Week Low
$22.40
$22.40$31.67
Current Yield
0.03%
Annual Dividend
$0.0308
Frequency
Quarterlyx/year
Last Ex-Date
Jun 4, 2026
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Jun 4, 2026 | $0.0228 | Jun 8, 2026 |
| Mar 5, 2026 | $0.0080 | Mar 9, 2026 |
Dividend Payments Over Time
Category Comparison
| Metric | QFRD | Technology(1770 ETFs) | S&P 500(474 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.49% | 0.65% | 0.70% |
| AUM | $1.7M | $3.67B | $8.66B |
| Dividend Yield | 0.03% | 2.94% | 3.95% |
| Avg Volume | 432 | 697.5K | 1.4M |
| Holdings | 52 | 150 | 109 |
| Performance | |||
| 1-Month Return | -12.04% | -10.95% | -5.51% |
| 6-Month Return | +0.77% | -8.92% | -2.90% |
| YTD Return | — | -1.73% | +1.02% |
| 1-Year Return | +14.66% | -2.08% | -0.16% |
Compare with Another ETF
Search for an ETF to compare with QFRD:
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.